File Download
  Links for fulltext
     (May Require Subscription)
  • Find via Find It@HKUL
Supplementary

Article: Gene therapy: an alternative strategy for correction of severe craniofacial deformities

TitleGene therapy: an alternative strategy for correction of severe craniofacial deformities
Authors
KeywordsAngiogenesis inhibitors
Craniofacial dysostosis
Gene therapy/methods
Rats
Issue Date2010
PublisherHong Kong Academy of Medicine Press. The Journal's web site is located at http://www.hkda.org/hkdj/index.php
Citation
Hong Kong Dental Journal, 2010, v. 7, p. 8-13 How to Cite?
AbstractObjective. Gene therapy is a novel strategy for correction of severe deformities. To test whether such therapy could be used to control condylar growth, an experimental model entailing Sprague-Dawley rats was developed. Methods. Either recombinant adenoassociated virus (rAAV)–mediated angiogenesis inhibitor (experimental group) or rAAVmediated reporter expressing green fluorescent protein (control group) was transduced into the temporomandibular joint of Sprague-Dawley rats for 3 weeks. Rats in both groups were sacrificed and samples were collected for image analysis, immunostaining, periodic acid-Schiff staining, and tartrate-resistant acid phosphatase staining. Vascular formations, bone formation, and osteoclast activities of the two groups were compared. Results. Virus vector–mediated angiogenesis inhibitor expression in condylar cartilage inhibited vascular formation, bone formation, osteoclast activity, and condylar growth. Conclusion. Gene therapy can be considered an alternative strategy for the correction of severe craniofacial growth deformities.
Persistent Identifierhttp://hdl.handle.net/10722/208095
ISSN

 

DC FieldValueLanguage
dc.contributor.authorLi, QF-
dc.contributor.authorWong, RWK-
dc.contributor.authorRabie, ABM-
dc.date.accessioned2015-02-11T02:22:20Z-
dc.date.available2015-02-11T02:22:20Z-
dc.date.issued2010-
dc.identifier.citationHong Kong Dental Journal, 2010, v. 7, p. 8-13-
dc.identifier.issn1727-2300-
dc.identifier.urihttp://hdl.handle.net/10722/208095-
dc.description.abstractObjective. Gene therapy is a novel strategy for correction of severe deformities. To test whether such therapy could be used to control condylar growth, an experimental model entailing Sprague-Dawley rats was developed. Methods. Either recombinant adenoassociated virus (rAAV)–mediated angiogenesis inhibitor (experimental group) or rAAVmediated reporter expressing green fluorescent protein (control group) was transduced into the temporomandibular joint of Sprague-Dawley rats for 3 weeks. Rats in both groups were sacrificed and samples were collected for image analysis, immunostaining, periodic acid-Schiff staining, and tartrate-resistant acid phosphatase staining. Vascular formations, bone formation, and osteoclast activities of the two groups were compared. Results. Virus vector–mediated angiogenesis inhibitor expression in condylar cartilage inhibited vascular formation, bone formation, osteoclast activity, and condylar growth. Conclusion. Gene therapy can be considered an alternative strategy for the correction of severe craniofacial growth deformities.-
dc.languageeng-
dc.publisherHong Kong Academy of Medicine Press. The Journal's web site is located at http://www.hkda.org/hkdj/index.php-
dc.relation.ispartofHong Kong Dental Journal-
dc.rightsHong Kong Dental Journal. Copyright © Hong Kong Academy of Medicine Press.-
dc.subjectAngiogenesis inhibitors-
dc.subjectCraniofacial dysostosis-
dc.subjectGene therapy/methods-
dc.subjectRats-
dc.titleGene therapy: an alternative strategy for correction of severe craniofacial deformitiesen_US
dc.typeArticleen_US
dc.identifier.emailWong, RWK: fyoung@hkucc.hku.hk-
dc.identifier.emailRabie, ABM: rabie@hkusua.hku.hk-
dc.identifier.hkuros171562-
dc.identifier.volume7-
dc.identifier.spage8-
dc.identifier.epage13-
dc.publisher.placeHong Kong-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats